Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Oleic Acid.
A monounsaturated omega-9 fatty acid that modulates membrane fluidity and activates G protein-coupled receptor 120 (GPR120) to exert anti-inflammatory and insulin-sensitizing effects.
445639
282.5 g/mol
6.5
(Z)-octadec-9-enoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Oleic Acid across standard consumer modalities.
As a liquid lipid at room temperature, oleic acid requires specialized softgel encapsulation or high-surface-area adsorbent carriers to prevent leakage and oxidation in dry powder hard-shell formats.
The high lipid load of oleic acid can destabilize pectin or gelatin matrices, leading to oil leaching and compromised structural integrity of the gummy.
The significant volumetric payload required for therapeutic dosing of oleic acid exceeds the thin-film capacity of oral strips, which typically accommodate only low-milligram active concentrations.
Ready to launch a product featuring Oleic Acid? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Oleic Acid extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Oleic Acid payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation